Juan Pablo Frias - Aug 31, 2023 Form 4 Insider Report for Biomea Fusion, Inc. (BMEA)

Role: Chief Medical Officer
Signature: /s/ Franco Valle as Attorney-in-Fact for Juan Pablo Frias
Stock symbol: BMEA
Transactions as of: Aug 31, 2023
Transactions value $: $0
Form type: 4
Date filed: 9/1/2023, 05:10 PM
Next filing: Jan 18, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BMEA	Stock Option (Right to Buy)	Award	$0	+300K		$0.00	300K	Aug 31, 2023	Common Stock	300K	$16.87	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	One-sixteenth (1/16th) of the total number of shares subject to the stock option shall vest and become exercisable at the end of the third month following August 31, 2023 and one-sixteenth (1/16th) of the total number of shares subject to the stock option shall vest and become exercisable quarterly thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date.

Content

One-sixteenth (1/16th) of the total number of shares subject to the stock option shall vest and become exercisable at the end of the third month following August 31, 2023 and one-sixteenth (1/16th) of the total number of shares subject to the stock option shall vest and become exercisable quarterly thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date.